Companies: 48,874 Total Market Cap: 132460447025120.92

Dna Group (T.R.) Ltd

TLV-DNA

Healthcare Biotechnology

Rank #31098

Market Cap 37.30 M

Volume 105,980

Price 30.80

Change (%) 1.68%

Country or region

Israel

Dna Group (T.R.) Ltd's latest marketcap:

37.30 M

As of 05/19/2025, Dna Group (T.R.) Ltd's market capitalization has reached $37.30 M. According to our data, Dna Group (T.R.) Ltd is the 31098th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap	37.30 M
Revenue (ttm)	86,616.36
Net Income (ttm)	6.25 M
Shares Out	123.16 M
EPS (ttm)	0.05
Forward PE	0.00
Ex-Dividend Date	n/a
Earnings Date	05/28/2025

Market Cap Chart

Data Updated: 05/19/2025

Dna Group (T.R.) Ltd's yearly market capitalization.

Dna Group (T.R.) Ltd has seen its market value grow from ₪22.90 M to ₪131.79 M since 2020, representing a total increase of 475.38% and an annual compound growth rate (CAGR) of 49.07%.

Date	Market Cap	Change (%)
05/19/2025	₪131.79 M	11.12%
12/31/2024	₪111.83 M	43.67%
12/31/2023	₪77.84 M	-10.57%
12/29/2022	₪87.04 M	-44.63%
12/30/2021	₪157.19 M	586.31%
12/31/2020	₪22.90 M

Company Profile

About Dna Group (T.R.) Ltd

Dna Group (T.R.) Ltd, along with its subsidiaries, specializes in the development, manufacturing, and marketing of patented ultrasound systems. The company operates globally, with a presence in Israel, North America, East Asia, and other international markets.

Core Offerings

Ultrasound Systems: Advanced diagnostic tools for assessing bone strength, density, and monitoring calcium leakage (osteoporosis) in both adults and children.
Target Users: Designed for skilled physicians, nurses, and operators in hospitals, clinics, pharmacies, and other healthcare settings.
Oral Drug Development: Engages in the research and development of innovative oral medications.

Corporate Background

Formerly known as D.N.A Biomedical Solutions Ltd., the company rebranded to Dna Group (T.R.) Ltd in November 2022. Founded in 2004, it is headquartered in Tel Aviv-Yafo, Israel.

Frequently Asked Questions

As of 05/19/2025, Dna Group (T.R.) Ltd (including the parent company, if applicable) has an estimated market capitalization of $37.30 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Dna Group (T.R.) Ltd global market capitalization ranking is approximately 31098 as of 05/19/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region	Israel
Founded	2004
IPO Date	n/a
Employees	n/a
CEO	Erez Navon
Sector	Healthcare
Industry	Biotechnology
Address	Shimon Hatars' 43 Tel Aviv, 6249245 Israel
Website